Shares of Advanced Oncotherapy PLC (LON:AVO) opened at 106.10 on Monday. The company’s market cap is GBX 60.19 million. Advanced Oncotherapy PLC has a one year low of GBX 98.00 and a one year high of GBX 217.25. The firm has a 50-day moving average of GBX 118.61 and a 200 day moving average of GBX 145.19.
In other news, insider Bradfield ,Michael acquired 30,000 shares of the stock in a transaction on Monday, July 11th. The shares were purchased at an average price of GBX 135 ($1.76) per share, for a total transaction of £40,500 ($52,865.16).
About Advanced Oncotherapy PLC
Advanced Oncotherapy Plc is a United Kingdom-based company. The Company is engaged in providing medical technology for cancer treatment and managing a health-related property. The Company operates in three business segments: Proton Therapy, Single Dose Intra-Operative Radiotherapy Treatment (SDIORT) and Healthcare related properties.
Receive News & Ratings for Advanced Oncotherapy PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy PLC and related companies with MarketBeat.com's FREE daily email newsletter.